EMPRESS

Empress Medical is changing the standard of care for fibroid treatment - one of the highest prevalence painful conditions amongst women especially black and ethnic women. Incorporated in Delaware, United States in 2019, our team is international and preparing rapidly to enter a pivotal clinical phase in the US... We are focused on changing the standard of care for women worldwide and reducing the number of hysterectomies by introducing an easy-to-use laparoscopic technology designed for gynecologists operating in average settings, making it accessible to more underserved women, and delivering on the promise to offer a broader base of women a safe uterus preserving fibroid treatment option and preserving fertility... Of women will develop uterine fibroid by the age of 50